TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT03817502: Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia

Sponsor: Gedeon Richter Plc. · Phase: PHASE3 · Area: CNS_NEUROLOGY · Target Enrollment: 330 pts

Competing Trials Overlap

14 Active Trials

Excess Burn Exposure

$4,242,392

Rescue Site Savings

+$2,809,896

Unlock Full NCT03817502 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT03817502 Rescue Dossier →